Nukkleus Inc.
OTC:NUKK
23.98 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 16.222 | 21.513 | 19.287 | 19.2 | 19.2 | 19.2 | 24 | 9.7 | 0.032 | 0.103 | 0.012 |
| Cost of Revenue
| 16.287 | 22.175 | 19.193 | 18.9 | 18.9 | 18.9 | 23.7 | 9.579 | 0.015 | 0.029 | 0.006 |
| Gross Profit
| -0.065 | -0.661 | 0.094 | 0.3 | 0.3 | 0.3 | 0.3 | 0.121 | 0.018 | 0.074 | 0.006 |
| Gross Profit Ratio
| -0.004 | -0.031 | 0.005 | 0.016 | 0.016 | 0.016 | 0.013 | 0.013 | 0.548 | 0.715 | 0.477 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 2.841 | 5.486 | 0.557 | 0.413 | 1.016 | 0.477 | 0.29 | 0.374 | 0.063 | 0.124 | 0.113 |
| Selling & Marketing Expenses
| 0.051 | 0.42 | 0.018 | 0 | 0 | 0 | 0.123 | 0 | 0 | 0 | 0.029 |
| SG&A
| 3.009 | 5.906 | 0.557 | 0.413 | 1.016 | 0.477 | 0.413 | 0.374 | 0.063 | 0.124 | 0.142 |
| Other Expenses
| 0.136 | 0.264 | 0.469 | 0.154 | 0.486 | 0.021 | 0.123 | 0 | 0 | 0.018 | 0 |
| Operating Expenses
| 3.207 | 6.17 | 1.026 | 0.413 | 1.016 | 0.477 | 0.413 | 0.374 | 0.063 | 0.124 | 0.142 |
| Operating Income
| -3.272 | -11.142 | -0.932 | -0.113 | -0.756 | -0.177 | -0.113 | -0.252 | -0.045 | -0.05 | -0.136 |
| Operating Income Ratio
| -0.202 | -0.518 | -0.048 | -0.006 | -0.039 | -0.009 | -0.005 | -0.026 | -1.391 | -0.488 | -11.324 |
| Total Other Income Expenses Net
| -0.003 | -0.703 | -0.004 | 0.013 | 0.026 | -0.035 | -0.024 | -0.008 | 0 | 0 | 0 |
| Income Before Tax
| -3.275 | -11.846 | -0.937 | -0.101 | -0.73 | -0.212 | -0.137 | -0.26 | -0.045 | -0.05 | -0.136 |
| Income Before Tax Ratio
| -0.202 | -0.551 | -0.049 | -0.005 | -0.038 | -0.011 | -0.006 | -0.027 | -1.391 | -0.488 | -11.324 |
| Income Tax Expense
| -0.003 | 4.311 | 0.004 | 0.006 | -0.034 | -0.177 | -0.098 | -0.248 | -0.045 | -0.05 | 0.002 |
| Net Income
| -3.272 | -16.156 | -0.941 | -0.107 | -0.696 | -0.212 | -0.137 | -0.26 | -0.045 | -0.05 | -0.137 |
| Net Income Ratio
| -0.202 | -0.751 | -0.049 | -0.006 | -0.036 | -0.011 | -0.006 | -0.027 | -1.391 | -0.488 | -11.449 |
| EPS
| -0.32 | -1.65 | -0.13 | -0.017 | -0.11 | -0.033 | -0.02 | -0.048 | -0.01 | -0.011 | -0.034 |
| EPS Diluted
| -0.33 | -1.65 | -0.13 | -0.017 | -0.11 | -0.033 | -0.02 | -0.048 | -0.01 | -0.011 | -0.034 |
| EBITDA
| -1.494 | -11.142 | -0.463 | -0.113 | -0.716 | -0.177 | -0.113 | -0.252 | -0.045 | -0.05 | -0.02 |
| EBITDA Ratio
| -0.092 | -0.225 | -0.024 | -0.006 | -0.037 | -0.009 | -0.005 | -0.026 | -1.391 | -0.488 | -1.667 |